VAX 2 STOP CANCER

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

BARBARA SCHULER

Phone

2059194329

Tax Period

2024-01-01 to 2024-12-31

VAX 2 STOP CANCER, founded in 2020, is a small nonprofit in the Health Care sector that reported $152K in total revenue in fiscal year 2024. Revenue fell 36% from the prior year — a significant decline worth monitoring. Expenses of $178K exceeded revenue, resulting in a 17% operating deficit.

Mission

TO PREVENT CANCER BY EXPANDING THE USE OF THE HUMAN PAPILLOMAVIRUS (HPV) VACCINE THROUGH EDUCATION, PUBLIC AWARENESS, AND ADVOCACY.

Program Service Accomplishments

Program 1

Expenses: $161,516

VAX 2 STOP CANCER TRAINS PEDIATRIC AND FAMILY MEDICINE PROVIDERS IN ALABAMA TO IMPROVE THEIR HPV VACCINATION RATE. SINCE OUR LAUNCH IN 2020, WE HAVE TRAINED 453 HEALTHCARE PROVIDERS AND STAFF AT 116 PRACTICES IN 42 ALABAMA COUNTIES WITH OUR HPV VACCINE PROVIDER EDUCATION PROGRAM TITLED PREVENTING HPV ASSOCIATED CANCERS THROUGH EFFECTIVE PROVIDER EDUCATION. IN TRAINING, PROVIDERS LEARN THE MOST EFFECTIVE METHOD FOR HPV VACCINE RECOMMENDATION STARTING AT AGE 9, RESEARCH-TESTED MESSAGING TO COUNSEL HESITANT PARENTS, AND STRATEGIES TO DECREASE MISSED OPPORTUNITIES TO GIVE THE VACCINE. VAX 2 STOP CANCER ALSO HAS A DENTAL PROVIDER EDUCATION PROGRAM. THE ONLINE PROGRAM TRAINS DENTISTS, PEDIATRIC DENTISTS, AND HYGIENISTS ON RECOMMENDING THE HPV VACCINE TO THEIR 9-26-YEAR-OLD PATIENTS. OROPHARYNGEAL CANCER IS NOW THE MOST FREQUENTLY DIAGNOSED HPV-ASSOCIATED CANCER, SURPASSING CERVICAL CANCER DIAGNOSES. HPV CAUSES 14,800 CASES OF OROPHARYNGEAL CANCER EACH YEAR IN THE US. THE HPV VACCINE RECOMMENDATION IS CRITICAL TO PREVENTING OROPHARYNGEAL CANCER AND ALL HPV CANCERS.BOTH OF THESE PROGRAMS UTILIZE METHODS ENDORSED BY THE NATIONAL CANCER INSTITUTE AND MATERIALS FROM THE UNIVERSITY OF NORTH CAROLINA AND THE NATIONAL HPV VACCINATION ROUNDTABLE. WE ALSO EDUCATE PARENTS, ADOLESCENTS, AND THE GENERAL PUBLIC ON THE SAFETY, EFFICACY, AND IMPORTANCE OF THE HPV VACCINE THROUGH OUR DIGITAL MEDIA PROGRAMS ON FACEBOOK, INSTAGRAM, TWITTER, LINKEDIN, AND TIKTOK.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $156,721

Program Service Revenue $0

Investment Income $0

Other Revenue $-4,768

TOTAL REVENUE $151,953

Expense Breakdown

Grants Paid $0

Salaries & Benefits $138,669

Fundraising Expenses $0

Program Expenses $161,516

Other Expenses $39,705

TOTAL EXPENSES $178,374

Year-over-Year Comparison

	2024	2023	Change
Revenue	$151,953	$236,809	-0.4%
Expenses	$178,374	$176,586	+0.0%
Net Income	$-26,421	$60,223	-1.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$63,179

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
STUART A LOCKWOOD DMD MPH	CHAIR	1.00	Officer Director	$0	$0	$0
GINNA WHITE	VICE CHAIR	1.00	Officer Director	$0	$0	$0
TAMERA COYNE-BEASLEY MDMPHFAAPFSA	BOARD MEMBER	1.00	Director	$0	$0	$0
PHILIP BRYAN	BOARD MEMBER	1.00	Director	$0	$0	$0
CASEY L DANIELD PHD MPH	BOARD MEMBER	1.00	Director	$0	$0	$0
LEIGH ANNE HODGE JD	BOARD MEMBER	1.00	Director	$0	$0	$0
COTY HULGAN DMD	BOARD MEMBER	1.00	Director	$0	$0	$0
MALLIE IRELAND	BOARD MEMBER	1.00	Director	$0	$0	$0
WILLIAM H JOHNSTON MD FAAP	BOARD MEMBER	1.00	Director	$0	$0	$0
TERRANCE MOULTRIE	BOARD MEMBER	1.00	Director	$0	$0	$0
TRACIE RICHTER	BOARD MEMBER	1.00	Director	$0	$0	$0
CAROLINE TAYLOR DMD	BOARD MEMBER	1.00	Director	$0	$0	$0
JENNIFER YOUNG-PIERCE MD MPH	BOARD MEMBER	1.00	Director	$0	$0	$0
BARBARA S SCHULER MPH	CEO	40.00	Officer	$63,179	$0	$63,179

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$151,953	$178,374	$150,903	$-26,421
2023	$236,809	$176,586	$177,324	$60,223